Phenotypic Landscape and Risk Management in Long QT Syndrome

被引：1
作者：
Grace, Andrew A. [1 ,2 ]
Matthews, Gareth D. K. [1 ]
机构：
[1] Cambridge Univ Hlth Partners, Royal Papworth Hosp NHS Fdn Trust, Cambridge, England
[2] Univ Cambridge, Dept Biochem, Cambridge, England
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2018年 / 71卷 / 15期
关键词：
arrhythmia; beta-blockers; long QT syndrome; BETA-ADRENOCEPTOR ANTAGONISTS; BLOCKER THERAPY;
D O I：
10.1016/j.jacc.2018.02.040
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1672 / 1675
页数：4
相关论文
共 24 条
  • [1] Efficacy of Different Beta-Blockers in the Treatment of Long QT Syndrome
    Abu-Zeitone, Abeer
    Peterson, Derick R.
    Polonsky, Bronislava
    McNitt, Scott
    Moss, Arthur J.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (13) : 1352 - 1358
  • [2] Beta-blocker therapy for long QT syndrome and catecholaminergic polymorphic ventricular tachycardia: Are all beta-blockers equivalent?
    Ackerman, Michael J.
    Priori, Silvia G.
    Dubin, Anne M.
    Kowey, Peter
    Linker, Nicholas J.
    Slotwiner, David
    Triedman, John
    Van Hare, George F.
    Gold, Michael R.
    [J]. HEART RHYTHM, 2017, 14 (01) : E41 - E44
  • [3] Effectiveness of beta-blockers depending on the genotype of congenital long-QT syndrome: A meta-analysis
    Ahn, Jinhee
    Kim, Hyun Jung
    Choi, Jong-Ii
    Lee, Kwang No
    Shim, Jaemin
    Ahn, Hyeong Sik
    Kim, Young-Hoon
    [J]. PLOS ONE, 2017, 12 (10):
  • [4] The selectivity of β-adrenoceptor antagonists at the human β1, β2 and β3 adrenoceptors
    Baker, JG
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2005, 144 (03) : 317 - 322
  • [5] BETA-1-ADRENERGIC-RECEPTOR AND BETA-2-ADRENERGIC-RECEPTOR SUBPOPULATIONS IN NONFAILING AND FAILING HUMAN VENTRICULAR MYOCARDIUM - COUPLING OF BOTH RECEPTOR SUBTYPES TO MUSCLE-CONTRACTION AND SELECTIVE BETA-1-RECEPTOR DOWN-REGULATION IN HEART-FAILURE-
    BRISTOW, MR
    GINSBURG, R
    UMANS, V
    FOWLER, M
    MINOBE, W
    RASMUSSEN, R
    ZERA, P
    MENLOVE, R
    SHAH, P
    JAMIESON, S
    STINSON, EB
    [J]. CIRCULATION RESEARCH, 1986, 59 (03) : 297 - 309
  • [6] β-blocker therapy failures in symptomatic probands with genotyped long-QT syndrome
    Chatrath, R
    Bell, CM
    Ackerman, MJ
    [J]. PEDIATRIC CARDIOLOGY, 2004, 25 (05) : 459 - 465
  • [7] Not All Beta-Blockers Are Equal in the Management of Long QT Syndrome Types 1 and 2
    Chockalingam, Priya
    Crotti, Lia
    Girardengo, Giulia
    Johnson, Jonathan N.
    Harris, Katy M.
    van der Heijden, Jeroen F.
    Hauer, Richard N. W.
    Beckmann, Britt M.
    Spazzolini, Carla
    Rordorf, Roberto
    Rydberg, Annika
    Clur, Sally-Ann B.
    Fischer, Markus
    van den Heuvel, Freek
    Kaeaeb, Stefan
    Blom, Nico A.
    Ackerman, Michael J.
    Schwartz, Peter J.
    Wilde, Arthur A. M.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (20) : 2092 - 2099
  • [8] Long-term follow-up of patients with long-QT syndrome treated with β-blockers and continuous pacing
    Dorostkar, PC
    Eldar, M
    Belhassen, B
    Scheinman, MM
    [J]. CIRCULATION, 1999, 100 (24) : 2431 - 2436
  • [9] FRISHMAN WH, 1981, NEW ENGL J MED, V305, P678
  • [10] The negative inotropic effect of β3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle
    Gauthier, C
    Leblais, V
    Kobzik, L
    Trochu, JN
    Khandoudi, N
    Bril, A
    Balligand, JL
    Le Marec, H
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (07) : 1377 - 1384
123